Pete T. Kissinger
Peter T. Kissinger, Ph.D., is the founder of Bioanalytical Systems, Inc., which he led from 1974-2007, and is Professor of Chemistry at Purdue University, West Lafayette, Indiana. Dr. Kissinger received a B.S. in Chemistry (1966) from Union College, Schenectady, N.Y. and a Ph.D. in Analytical Chemistry (1970) from the University of North Carolina in Chapel Hill. Prior to joining the faculty at Purdue in 1975, Kissinger was a Research Associate at the University of Kansas (1970-1972) and an Assistant Professor at Michigan State University (1972-1975). He founded BASi in 1974. Headquartered in West Lafayette, Indiana, BASi also has operations in Evansville; Baltimore; McMinnville, OR; and the U.K. The company manufactures instrumentation and develops software for pharmaceutical research, and carries out contract bioanalytical, pharmacological and toxicological research for pharmaceutical and biotechnology companies. BASi Vetronics manufactures instrumentation for veterinary medicine. Dr. Kissinger’s academic research has involved the study of modern liquid chromatography techniques, and in vivo methodology for drug metabolism and the neurosciences. Dr. Kissinger has published more than 230 scientific papers and is a Fellow of the American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. In 2005, he became the Chairman of Prosolia, which markets mass spectrometry innovations for life science, industrial and homeland security applications. In 2007, he and Candice Kissinger founded Phlebotics, Inc., a medical device company focused on diagnostic information for intensive care medicine. In 2008, Professor Kissinger is the Associate Head of the Department of Chemistry at Purdue University.